CLOSE X
GO

WOC Pharma and Healthcare Fund-Reg(G)

very highequitypharma & health care
14.15 -0.13(-0.89%) NAV as on 31 Jul 2025
4.51 % 1 M
22.75 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.38

As on 30 Jun, 2025
age-icon Age :

1 yrs 5 m

Since 06 02 ,2024
exit_load Exit Load :

1%

aum AUM :

364.10 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

9.4

Min_Investment Min. Investment :

SIP 100 & Lumpsum 500

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Ramesh Mantri,Dheeresh Pathak,Piyush Baranwal

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jun 30 ,2025
Debt 2.82 %
Others 4.72 %
Equity 92.46 %

TOP HOLDINGS

Max Healthcare Institute Ltd.7.97 %
Sun Pharmaceutical Industries...7.32 %
Divi's Laboratories Ltd.7.09 %
Fortis Healthcare Ltd.5.56 %
Cipla Ltd.5.21 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs60.54
Hospital & Healthcare Services27.43
Plastic Products1.51
Chemicals1.20
Medical Equipment/Supplies/Accessories1.12
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-2025
NAV in Rs (as on 31-Mar-2025)9.9612.74
Net Assets(Rs Crores) (as on 31-Mar-2025) 108.61 303.62
Scheme Returns(%)(Absolute)-0.4426.85
B'mark Returns(%)(Absolute)NANA
Category Rank85/902/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

WOC Pharma and Healthcare Fund-Reg(G)Very HighEquity14.15-0.13(-0.89%)NAV As on 31 Jul, 202506-Feb-2024Inception Date364.10AUM In Cr.22.75%1YNA%3YNA%5Y26.37%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.470.07(0.17%)NAV As on 31 Jul, 202513-Jul-2018Inception Date5,727.59AUM In Cr.17.05%1Y29.50%3Y23.89%5Y22.35%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity444.30-0.66(-0.15%)NAV As on 31 Jul, 202514-Jul-1999Inception Date3,849.24AUM In Cr.16.84%1Y28.21%3Y23.15%5Y16.40%Since Inception
Nippon India Pharma Fund(G)Very HighEquity530.79-6.01(-1.12%)NAV As on 31 Jul, 202505-Jun-2004Inception Date8,569.15AUM In Cr.8.47%1Y24.46%3Y20.23%5Y20.64%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors